logo
Virus-Outbreak-Novavax-Booster
ASSOCIATED PRESS

US clear Novavax COVID booster dose

The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax

By AP News
Published - Oct 19, 2022, 04:02 PM ET
Last Updated - Jun 24, 2023, 02:12 AM EDT

WASHINGTON (AP) — U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax.

The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the updated omicron-targeting Pfizer or Moderna boosters for medical or accessibility reasons -- or who otherwise would not receive a COVID-19 booster shot at all.

The FDA specified the additional Novavax shot was to be used as a first booster -- not for people who've already had one or more booster doses already — at least six months after completing their primary shots.

Novavax's initial two-dose shots have been available since the summer. Novavax is a protein-based vaccine unlike the other COVID-19 vaccines available in the U.S. including Pfizer, Moderna or Johnson & Johnson.

Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
4.2 12182024